Publication: The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells
6
Issued Date
2009-06-01
Resource Type
ISSN
15210103
00223565
00223565
Other identifier(s)
2-s2.0-66749132080
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Pharmacology and Experimental Therapeutics. Vol.329, No.3 (2009), 865-874
Suggested Citation
Kiyoshi Kikuchi, Ko Ichi Kawahara, Salunya Tancharoen, Fumiyo Matsuda, Yoko Morimoto, Takashi Ito, Kamal Krishna Biswas, Kazunori Takenouchi, Naoki Miura, Yoko Oyama, Yuko Nawa, Noboru Arimura, Masahiro Iwata, Yutaka Tajima, Terukazu Kuramoto, Kenji Nakayama, Minoru Shigemori, Yoshihiro Yoshida, Teruto Hashiguchi, Ikuro Maruyama The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. Journal of Pharmacology and Experimental Therapeutics. Vol.329, No.3 (2009), 865-874. doi:10.1124/jpet.108.149484 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/27216
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells
Author(s)
Kiyoshi Kikuchi
Ko Ichi Kawahara
Salunya Tancharoen
Fumiyo Matsuda
Yoko Morimoto
Takashi Ito
Kamal Krishna Biswas
Kazunori Takenouchi
Naoki Miura
Yoko Oyama
Yuko Nawa
Noboru Arimura
Masahiro Iwata
Yutaka Tajima
Terukazu Kuramoto
Kenji Nakayama
Minoru Shigemori
Yoshihiro Yoshida
Teruto Hashiguchi
Ikuro Maruyama
Ko Ichi Kawahara
Salunya Tancharoen
Fumiyo Matsuda
Yoko Morimoto
Takashi Ito
Kamal Krishna Biswas
Kazunori Takenouchi
Naoki Miura
Yoko Oyama
Yuko Nawa
Noboru Arimura
Masahiro Iwata
Yutaka Tajima
Terukazu Kuramoto
Kenji Nakayama
Minoru Shigemori
Yoshihiro Yoshida
Teruto Hashiguchi
Ikuro Maruyama
Abstract
Edaravone, a potent free radical scavenger, is clinically used for the treatment of cerebral infarction in Japan. Here, we examined the effects of edaravone on the dynamics of high-mobility group box-1 (HMGB1), which is a key mediator of ischemic-induced brain damage, during a 48-h postischemia/ reperfusion period in rats and in oxygen-glucose-deprived (OGD) PC12 cells. HMGB1 immunoreactivity was observed in both the cytoplasm and the periphery of cells in the cerebral infarction area 2 h after reperfusion. Intravenous administration of 3 and 6 mg/kg edaravone significantly inhibited nuclear translocation and HMGB1 release in the penumbra area and caused a 26.5 ± 10.4 and 43.8 ± 0.5% reduction, respectively, of the total infarct area at 24 h after reperfusion. Moreover, edaravone also decreased plasma HMGB1 levels. In vitro, edaravone dose-dependently (1-10 μM) suppressed OGD- and H2O2-induced HMGB1 release in PC12 cells. Furthermore, edaravone (3-30 μM) blocked HMGB1-triggered apoptosis in PC12 cells. Our findings suggest a novel neuroprotective mechanism for edaravone that abrogates the release of HMGB1. Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics.